U-Neuron Biomedical Inc
6973
Rank in Stocks
#20947
U-Neuron Biomedical Inc. specializes in the pioneering development of stem cell... U-Neuron Biomedical Inc. specializes in the pioneering development of stem cell technologies. The company's core activities revolve around advancing methods for stem cell preservation, isolation, and their subsequent application in therapeutic treatments. Their research specifically targets Amniotic Fluid Stem Cells, Olfactory Stem Cells, and Adipose-derived Stem Cells. This enterprise was established on September 4, 2015, and is based in New Taipei, Taiwan.
Share Price
$1.72
Last synced: 2026-11-10
Market Cap
$75.86M
Change (1 day)
-0.53%
Change (1 year)
28.30%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade U-Neuron Biomedical Inc (6973)
Category
Healthcare
Operating Margin for U-Neuron Biomedical Inc (6973)
Operating Margin as of November 2026 TTM: -70.91%
According to U-Neuron Biomedical Inc's latest financial reports, its current operating margin (TTM) is -70.91%. At the end of 2025 the company had an operating margin of -78.85%.
Operating Margin history for U-Neuron Biomedical Inc from 2020 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -70.91% | -10.07% |
| 2025 | -78.85% | -47.16% |
| 2024 | -149.23% | -55.35% |
| 2023 | -334.24% | 105.00% |
| 2022 | -163.04% | 207.51% |
| 2021 | -53.02% | 0.00% |
| 2020 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.54% |
US
|
|
| -149.01% | -97.90% |
US
|
|
| 25.57% | -100.36% |
AU
|
|
| 31.23% | -100.44% |
BE
|
|
| 29.35% | -100.41% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about U-Neuron Biomedical Inc's operating margin
What is U-Neuron Biomedical Inc's operating margin?
U-Neuron Biomedical Inc's operating margin is -70.91%, as of Nov 2026.
What was U-Neuron Biomedical Inc's operating margin in 2025?
In 2025, U-Neuron Biomedical Inc's operating margin was -78.85%, compared with -149.23% in 2024.
How has U-Neuron Biomedical Inc's operating margin changed since 2020?
From 2020 to 2025, U-Neuron Biomedical Inc's operating margin was highest in 2020 (0.00%) and lowest in 2023 (-334.24%).
How does U-Neuron Biomedical Inc's operating margin compare with similar companies?
U-Neuron Biomedical Inc's operating margin (-70.91%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.